DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Mato AR, Timlin C, Ujjani C, Skarbnik A, Howlett C, Banerjee R. et al.
Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: Results from a multi-centre study.
Br J Haematol 2018;
181: 259-61
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.